8-K
Medinotec Inc. (MDNC)
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549____________________
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934 Date
of Report (Date of earliest event reported): January 20, 2026
Medinotec, Inc.
(Exact name of registrant as specified in its charter)
| Nevada | 000-56737 | 36-4990343 | |||
|---|---|---|---|---|---|
| (State or other jurisdiction of incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) | |||
| Northlands Deco Park | 10 New Market Street | Stand<br> 299 Avant Garde Avenue<br><br> <br>North Riding | Johannesburg<br> | South Africa | 2169 |
| --- | --- | ||||
| (Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including area code: +27 87 330
2301
| ________________________________________________<br><br> <br>(Former name or former address, if changed since last<br> report) |
|---|
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| [ ] | Written communications pursuant to Rule 425 under the Securities Act (17CFR 230.425) |
|---|---|
| [ ] | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| [ ] | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| [ ] | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act: None.
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company [X]
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]
SECTION 5 – Corporate Governance and Management
Item 5.07 Submission of Matters to a Vote of Security Holders.
On January 20, 2026, we held our 2025 Annual Meeting of the shareholders, at which the shareholders voted on the matters disclosed in our Proxy Statement. The final voting results for the matters submitted to a vote of the shareholders were as follows:
Proposal No. 1 - Election of Directors
Our shareholders elected the persons listed below for a one-year term expiring at our 2026 Annual Meeting or until their respective successors are duly elected and qualified:
| FOR | AGAINST | ABSTAIN | |
|---|---|---|---|
| Gregory Vizirgianakis | 9,955,835 | 0 | 0 |
| Pieter van Niekerk | 9,955,835 | 0 | 0 |
| Stavros G. Vizirgianakis | 9,955,835 | 0 | 0 |
| Joseph P. Dwyer | 9,955,835 | 0 | 0 |
| Athanasios Spirakis | 9,955,835 | 0 | 0 |
Proposal No. 2 – Ratification of Independent Registered PublicAccounting Firm
Our shareholders ratified the appointment of Mercurius & Associates LLP as our independent registered public accounting firm for fiscal 2026.
| FOR | AGAINST | ABSTAIN |
|---|---|---|
| 9,955,835 | 0 | 0 |
| 2 |
| --- |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Medinotec, Inc.
/s/ Pieter van Niekerk
Pieter van Niekerk
Chief Financial Officer
Date: January 20, 2026
| 3 |
| --- |